MedPath

Cognitive Stimulation Therapy and Olderly People With Mild Cognitive Impairment

Not Applicable
Completed
Conditions
Mild Cognitive Impairment
Interventions
Behavioral: Cognitive Stimulation Therapy
Registration Number
NCT06115785
Lead Sponsor
Ejdane Coskun
Brief Summary

The aim of this study is to examine the effect of cognitive stimulation therapy on cognitive status and apathy in elderly individuals with mild cognitive impairment.

Detailed Description

This randomized controlled experimental study is planned for 30 October - 25 December 2023, with a total of 60 people (30 in the control group and 30 in the intervention group) at the Elderly Care and Rehabilitation Center. The data of the research were collected from the Literature-Based Personal Information Form, Standardized Mini Mental Test (SMMT), Apathy Assessment Scale. Approval from the Clinical Research Ethics Committee and written permission from the participants were obtained to conduct the study. Individuals in the intervention group started with introduction and in the first week, pre-test administration and CST will be administered twice for 45 minutes.

For the next 7 weeks, it will be carried out for one week, with the introduction and pre-test application for individuals in the control group in the first week. They will continue their daily lives in two sessions for one week and two days. They will continue their lives in the following weeks.

Written informed consent form will be given to all individuals in the study. It will start after information about the measurement tools is given.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Agree to participate in the study
  • Being literate and speaking Turkish fluently
  • Have communication and understanding skills
  • Standardized Mini Mental Test result being between 18-23 points
  • Having adequate vision and hearing functions for group participation
Exclusion Criteria
  • Presence of any sensory impairment
  • Having a physical health problem that may impair group cohesion and integrity

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cognitive Stimulation TherapyCognitive Stimulation TherapyCognitive Stimulation Therapy In the 2nd, 3rd, 4th, 6th, 7th and 8th weeks, IPT implementation twice a week, as two themes, for 7 weeks, with each session of 45 minutes.
Primary Outcome Measures
NameTimeMethod
Standardized Mini Mental Test (SMMT)up to 9 weeks

This test consists of 11 items grouped into five subgroups measuring cognitive functions: orientation, recording memory, attention and calculation, recall and language. In SMMT, which is evaluated out of a total of 30 points, one point is given for each correct answer. Although scores of 23/24 for SMMT are considered the limit score for dementia; SMMT score between 18-23 points is considered as mild stage, 10-17 points as moderate stage, and 10 points or less as severe dementia.

Secondary Outcome Measures
NameTimeMethod
Apathy Rating Scale (ARS)up to 9 weeks

ARS focuses on the hobbies and pursuits of the individual in his daily life and his enjoyment of them, and measures his loss in these areas.ARS contains a total of 18 items and provides a four-point Likert type measurement. Scores are given between 1 and 4, with 1 representing not at all characteristic and 4 representing very characteristic.The 6th, 10th and 11th items of the scale are in the reverse direction and scoring is done in the reverse direction accordingly.The total score of ARS is found by summing the scores obtained from each of the items and is 18-72.

Trial Locations

Locations (1)

Türkiye

🇹🇷

Osmaniye, Korkut Ata University, Turkey

© Copyright 2025. All Rights Reserved by MedPath